AU8107998A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU8107998A
AU8107998A AU81079/98A AU8107998A AU8107998A AU 8107998 A AU8107998 A AU 8107998A AU 81079/98 A AU81079/98 A AU 81079/98A AU 8107998 A AU8107998 A AU 8107998A AU 8107998 A AU8107998 A AU 8107998A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81079/98A
Inventor
David Michael Barrett
Huw Lyn Jones
Idwal Jones
Carl Simon Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710505.0A external-priority patent/GB9710505D0/en
Priority claimed from GBGB9710544.9A external-priority patent/GB9710544D0/en
Priority claimed from GBGB9710527.4A external-priority patent/GB9710527D0/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of AU8107998A publication Critical patent/AU8107998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
AU81079/98A 1997-05-22 1998-05-22 Pharmaceutical compositions Abandoned AU8107998A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9710544 1997-05-22
GBGB9710505.0A GB9710505D0 (en) 1997-05-22 1997-05-22 Pharmaceutical compositions
GBGB9710544.9A GB9710544D0 (en) 1997-05-22 1997-05-22 Medical treatment
GBGB9710527.4A GB9710527D0 (en) 1997-05-22 1997-05-22 Pharmaceutical compositions
GB9710527 1997-05-22
GB9710505 1997-05-22
PCT/EP1998/003179 WO1998052540A1 (en) 1997-05-22 1998-05-22 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU8107998A true AU8107998A (en) 1998-12-11

Family

ID=27268849

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81079/98A Abandoned AU8107998A (en) 1997-05-22 1998-05-22 Pharmaceutical compositions

Country Status (2)

Country Link
AU (1) AU8107998A (en)
WO (1) WO1998052540A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US7588793B1 (en) 1998-06-05 2009-09-15 Cadbury Adams Usa, Llc Enhanced flavoring compositions containing N-ethyl-p-menthane-3-carboxamide and method of making and using same
US6558618B1 (en) * 1999-04-27 2003-05-06 James L Dent, Jr. Anti-infection formulation and delivery method
WO2001028533A2 (en) * 1999-10-19 2001-04-26 Kain Kevin C PRODUCTS AND METHODS FOR ACTIVATING PPARη-RXR AND UP-REGULATING MONOCYTE/MACROPHAGE CD36 FOR THE TREATMENT OF MALARIA
EP1234508A1 (en) * 2001-02-21 2002-08-28 Universiteit Gent Antiprotozoal methods, compositions and feedstuffs
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
DE10300222A1 (en) * 2003-01-03 2004-07-15 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Use of active substances for the prophylaxis and / or therapy of viral diseases
MY138409A (en) * 2003-11-19 2009-05-29 Yung Shin Pharm Ind Co Ltd Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
FR2865648B1 (en) 2004-02-03 2006-06-30 Philippe Perovitch METHOD FOR DIFFUSION OF INSOLUBLE MOLECULES IN AQUEOUS MEDIUM AND COMPOSITION IMPLEMENTING SAID METHOD
ITMI20040235A1 (en) * 2004-02-13 2004-05-13 Therapicon Srl PHARMACEUTICAL PREPARATION FOR THE ORAL CABLE
CA2576375C (en) 2004-08-11 2010-12-21 Cadbury Adams Usa Llc Sensate compositions and delivery systems therefor
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
AU2006342783B2 (en) 2005-12-23 2010-09-23 Intercontinental Great Brands Llc Compositions providing a heating sensation for oral or dermal delivery
GB201021267D0 (en) 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
DE102011111944A1 (en) 2011-08-29 2013-02-28 Richard A. Huthmacher Use of diclofenac for the prevention and treatment of influenza infections as well as disease symptoms caused by influenza infections
PT2965759T (en) 2012-02-06 2020-02-07 Innovative Med Concepts Llc Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes
CA3151044A1 (en) * 2019-08-22 2021-02-25 Applied Biological Laboratories, Inc. Compositions and methods using non-steroidal anti-inflammatory drugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62298528A (en) * 1986-06-16 1987-12-25 Yutaka Mizushima Troche for remedy of pharyngeal pain
CA2064722C (en) * 1989-08-17 2001-05-08 William J. Wechter Buccal composition containing s(+) flurbiprofen or ketoprofen
JPH0426618A (en) * 1990-05-21 1992-01-29 Japan Tobacco Inc Troche
WO1994013280A1 (en) * 1992-12-04 1994-06-23 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
ES2211916T3 (en) * 1994-09-02 2004-07-16 Virginia Commonwealth University COMPOSITION TO RELIEF PAIN, CONTAINING A NON-NARCORTIC ANALGESIC AND AN ANALGESIC POTENTIATOR.
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU2190697A (en) * 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule

Also Published As

Publication number Publication date
WO1998052540A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
AU6740298A (en) Pharmaceutical composition
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU5575398A (en) Hairdye compositions
AU5274096A (en) Pharmaceutical compositions
IL131995A0 (en) Gastric-retained pharmaceutical compositions
AU9343098A (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
GB9726735D0 (en) Pharmaceutical compositions
AUPP332898A0 (en) Pharmaceutical composition
HU9700632D0 (en) Pharmaceutical compositions
AU4326197A (en) Pharmaceutical compositions
AU2087897A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
AUPP053197A0 (en) Compositions
GB9921495D0 (en) Pharmaceutical compositions
AU1222799A (en) Antimalaria pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase